Alpha‐Tocopherol supplementation reduces inflammation and apoptosis in high cholesterol mediated nonalcoholic steatohepatitis. (8th June 2021)

• Record Type: Journal Article
• Authors: Demirel‐Yalciner, Tugce; Sozen, Erdi; Ozaltin, Esra; Sahin, Ali; Ozer, Nesrin Kartal
• Is Part Of: BioFactors. Volume 47:Number 3(2021)
• Page Start: 403
• Page End: 413
• Publication Date: 2021-06-08
• Subjects: apoptosis -- fibrosis -- high cholesterol diet -- inflammation -- NASH -- α‐tocopherol; Vitamins -- Physiological effect -- Periodicals; Trace elements -- Physiological effect -- Periodicals; Growth factors -- Physiological effect -- Periodicals; Plant growth promoting substances -- Physiological effect -- Periodicals; Biochemistry -- Periodicals; Nutritional Physiological Phenomena -- Periodicals; Trace Elements -- metabolism -- Periodicals; Vitamins -- metabolism -- Periodicals; Molecular Biology -- Periodicals; 612.399
• DOI: 10.1002/biof.1700
• Languages: English
• ISSNs: 0951-6433

Abstract

Abstract: Inflammation and apoptosis signaling are crucial steps in the progression from nonalcoholic fatty liver disease (NAFLD) to nonalcoholic steatohepatitis (NASH). Alpha‐tocopherol, the most active form of vitamin E, is an important modulator of signaling mechanisms, but its involvement to cholesterol‐induced NASH pathogenesis remains poorly defined. Herein we have reported a novel effect of α‐tocopherol in the transition from hepatic steatosis to NASH. High cholesterol diet alone (without α‐tocopherol) in rabbits elevated NASH development as indicated by increased inflammatory response, apoptotic activity and liver fibrosis. Such elevation results from induction of signaling mechanisms since the expressions of IL1β, phospho c‐Jun/c‐Jun ratio, JNK, caspase 9, CHOP and Bax were increased, and recruitment of macrophage, α‐smooth muscle actin (α‐SMA) and COL1A1 into the liver tissue were induced. Alpha‐tocopherol supplementation inhibited inflammatory response, apoptosis and fibrosis development without affecting lipid accumulation in high cholesterol‐induced NASH. Specifically, α‐tocopherol lowered the inflammatory level as observed by reduced macrophage infiltration and JNK/c‐Jun signaling. Lower inflammatory status co‐occurred with the reduction of CHOP and Bax expressions as well as fibrosis‐related COL1A1 and α‐SMA levels. Taken together, α‐tocopherol supplementation inhibits cholesterol‐induced NASH development by lowering JNK/c‐Jun/inflammation axis in addition to JNK/CHOP/apoptosis signaling, which might contribute to resistance against NAFLD/NASH transition.